Catalyst Wire Dossier Catalyst Wire Dossier

OK-432

Streptococcal pyrogenic exotoxin-based immunotherapy (picibanil)
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OK-432, covering 2009-03-03 to 2016-10-14. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak [NA]

See pricing